UK Companies House feature
VERTICAL PHARMA RESOURCES LIMITED
Cash
£2M
+80.9% vs 2024
Net assets
£9M
+152.6% vs 2024
Employees
89
+12.7% vs 2024
Profit before tax
£5M
+199.9% vs 2024
Profile
- Company number
- 06077026
- Status
- Active
- Incorporation
- 2007-02-01
- Last accounts made up
- 2025-02-28
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Profit before tax
4-year trend · vs UK Healthcare median
Accounts
4-year trend · latest 2025-02-28
| Metric | Trend | 2022-02-28 | 2023-02-28 | 2024-02-28 | 2025-02-28 |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | — | — | — | — | |
| Profit before tax | £1,308,639 | -£98,729 | £1,826,668 | £5,477,346 | |
| Net profit | £1,316,639 | £6,689 | £1,841,634 | £5,333,196 | |
| Cash | £942,616 | £645,845 | £1,377,597 | £2,491,939 | |
| Total assets less current liabilities | £1,646,915 | £1,653,604 | £3,495,238 | £8,828,434 | |
| Net assets | — | — | — | — | |
| Equity | £1,646,915 | £1,653,604 | £3,495,238 | £8,828,434 | |
| Average employees | 79 | 77 | 79 | 89 | |
| Wages | £2,936,800 | £3,209,683 | £3,336,249 | £4,125,986 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Gerald Edelman LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“As a result of the above the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future, being a period of not less than twelve months from the date of approval of these financial statements and continue to adopt the going concern basis of accounting in preparing the financial statements.”
Subsidiaries
- Grow Pharma Limited · 49% held · Education and market access Services
- Integro Medical Clinics Limited · 60% held · Private medical clinic
Significant events
- “Subsequent to the year end, the Group's main loan note holders formally extended the repayment date of these loans from 30 June 2025 to 30 June 2028 and the financial covenants amended to create sufficient headroom against base case forecast.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PATEL, Ashokkumar Dahyabhai | Secretary | 2007-02-01 | — | British |
| DUTTA, Soimitra Tony | Director | 2018-09-27 | Apr 1963 | British |
| PARKER, James, Dr | Director | 2019-05-01 | Aug 1955 | British |
| PATANI, Vishal | Director | 2018-09-27 | Sep 1977 | British |
| PATEL, Ashokkumar Dahyabhai | Director | 2007-02-01 | Feb 1956 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| TEMPLE SECRETARIES LIMITED | Corporate Nominee Secretary | 2007-02-01 | 2007-02-01 |
| JOHN, Iain Martyn | Director | 2012-01-18 | 2013-02-08 |
| JONES-OWEN, David | Director | 2013-02-08 | 2015-06-30 |
| PANDYA, Anant Kumar | Director | 2007-08-07 | 2010-04-30 |
| PATEL, Girish Kumar Ratilal | Director | 2007-08-07 | 2012-01-18 |
| PATEL, Ramesh Vasudev | Director | 2007-02-01 | 2010-04-30 |
| PENFOLD, Jonathan Mark | Director | 2016-06-23 | 2019-05-10 |
| SHAH, Kiritkumar Meghji | Director | 2007-02-01 | 2007-03-01 |
| STEPHENSON, Robert Mark | Director | 2013-11-21 | 2014-11-19 |
| STEVENS, David William | Director | 2010-04-30 | 2011-02-24 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Integrated Pharmaceutical Services (Ips) Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-05-17 | Active |
Filing timeline
Last 20 of 86 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-07-29 | AA | accounts | accounts with accounts type full |
| 2025-01-27 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-06-26 | AA | accounts | accounts with accounts type full |
| 2024-01-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-12-14 | AA | accounts | accounts with accounts type full |
| 2023-07-14 | AA | accounts | accounts with accounts type full |
| 2023-01-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-01-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-01-08 | AA | accounts | accounts with accounts type small |
| 2021-06-15 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2021-06-09 | AA | accounts | accounts with accounts type small |
| 2021-05-18 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2021-05-18 | PSC09 | persons-with-significant-control | withdrawal of a person with significant control statement |
| 2021-05-11 | DISS40 | gazette | gazette filings brought up to date |
| 2021-05-04 | GAZ1 | gazette | gazette notice compulsory |
| 2021-01-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-01-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-12-24 | AA | accounts | accounts with accounts type small |
| 2019-05-22 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
28.6
COLD
/ 100
- Filings velocity 17
- Capital events 0
- Officer churn 0
- Headcount trajectory 63
- Accounts trajectory 100
- 2 filing(s) in last 12 months
- Employees +13% YoY
- Total Assets Less Current Liabilities +153% YoY